Lindbrook Capital, LLC Genmab A/S Transaction History

Lindbrook Capital, LLC

$1.18 Billion
Q3 2024

A detailed history of Lindbrook Capital, LLC transactions in Genmab A/S stock. As of the latest transaction made, Lindbrook Capital, LLC holds 901 shares of GMAB stock, worth $18,551. This represents 0.0% of its overall portfolio holdings.

Number of Shares

901

Previous 881 2.27%

Holding current value

$18,551

Previous $22,000 4.55%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$23.84 - $28.48 $476 - $569	20 Added 2.27%	901 $21,000
Q2 2024 Jul 31, 2024	SELL	$25.13 - $30.27 $5,528 - $6,659	-220 Reduced 19.98%	881 $22,000
Q1 2024 Apr 25, 2024	SELL	$26.43 - $32.77 $5,550 - $6,881	-210 Reduced 16.02%	1,101 $32,000
Q4 2023 Jan 31, 2024	SELL	$27.94 - $35.44 $2,877 - $3,650	-103 Reduced 7.28%	1,311 $41,000
Q3 2023 Oct 25, 2023	SELL	$35.27 - $42.24 $811 - $971	-23 Reduced 1.6%	1,414 $49,000
Q2 2023 Jul 28, 2023	BUY	$37.4 - $42.94 $1,047 - $1,202	28 Added 1.99%	1,437 $54,000
Q1 2023 Apr 26, 2023	BUY	$34.88 - $43.22 $697 - $864	20 Added 1.44%	1,409 $53,000
Q4 2022 Jan 24, 2023	BUY	$33.8 - $47.06 $5,340 - $7,435	158 Added 12.84%	1,389 $0
Q3 2022 Nov 10, 2022	BUY	$31.52 - $373.61 $10,275 - $121,796	326 Added 36.02%	1,231 $40,000
Q2 2022 Aug 01, 2022	SELL	$26.83 - $38.57 $7,780 - $11,185	-290 Reduced 24.27%	905 $29,000
Q1 2022 Apr 21, 2022	SELL	$30.95 - $39.68 $1,857 - $2,380	-60 Reduced 4.78%	1,195 $43,000
Q4 2021 Jan 18, 2022	SELL	$35.87 - $47.12 $358 - $471	-10 Reduced 0.79%	1,255 $50,000
Q3 2021 Nov 05, 2021	BUY	$41.55 - $48.72 $4,155 - $4,872	100 Added 8.58%	1,265 $55,000
Q2 2021 Jul 27, 2021	SELL	$32.88 - $44.57 $3,616 - $4,902	-110 Reduced 8.63%	1,165 $48,000
Q1 2021 Apr 28, 2021	BUY	$30.92 - $44.4 $4,019 - $5,772	130 Added 11.35%	1,275 $42,000
Q4 2020 Jan 27, 2021	SELL	$33.66 - $40.76 $639 - $774	-19 Reduced 1.63%	1,145 $47,000
Q3 2020 Nov 03, 2020	SELL	$33.07 - $38.68 $27,481 - $32,143	-831 Reduced 41.65%	1,164 $43,000
Q2 2020 Jul 27, 2020	BUY	$20.05 - $33.89 $10,125 - $17,114	505 Added 33.89%	1,995 $68,000
Q1 2020 Apr 22, 2020	SELL	$17.15 - $25.22 $23,152 - $34,047	-1,350 Reduced 47.54%	1,490 $32,000
Q4 2019 Jan 27, 2020	BUY	$18.88 - $24.14 $53,619 - $68,557	2,840 New	2,840 $63,000

Others Institutions Holding GMAB

# of Institutions

236

Shares Held

52.5M

Call Options Held

10.2K

Put Options Held

25.5K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Account

Lindbrook Capital, LLC Genmab A/S Transaction History